Basel, Switzerland

Peter Steidle


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Steidle

Introduction

Peter Steidle is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target cancer treatment. With a total of 3 patents to his name, Steidle's work has the potential to impact the medical community profoundly.

Latest Patents

Among his latest patents, Steidle has developed pharmaceutical compositions comprising AKT protein kinase inhibitors. These inventions focus on therapeutic activities against diseases such as cancer. The processes for their preparation and their use as medicaments highlight the innovative nature of his work in the pharmaceutical industry.

Career Highlights

Throughout his career, Peter Steidle has worked with prominent companies in the pharmaceutical sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations

Steidle has collaborated with several professionals in his field, including Reinhard Reents and Pirmin Hidber. These partnerships have likely enhanced the quality and scope of his inventions, fostering a collaborative environment for innovation.

Conclusion

Peter Steidle's contributions to pharmaceutical innovations, particularly in cancer treatment, demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…